Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2169
doi: 10.1161/CIRCULATIONAHA.107.189188
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;117:2169.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome
 
The congenital long-QT syndrome (LQTS) is an important cause of sudden cardiac death in young individuals without structural heart disease. However, data on risk factors for life-threatening cardiac events in children with this genetic disorder are limited. The present study assessed the risk of aborted cardiac arrest or sudden cardiac death in a population of 3015 LQTS children 1 through 12 years of age who were enrolled in the International LQTS Registry. Using time-dependent multivariable analysis, we identified male gender, QTc duration, and a history of prior syncope as risk factors for life-threatening cardiac events in LQTS children. Furthermore, we demonstrate that significant interactions exist among these 3 clinical risk factors that may be used to identify risk subsets in this population. Notably, β-blocker therapy is shown to be associated with a significant reduction in the risk of life-threatening cardiac events during childhood, with a more pronounced benefit (73% risk reduction) in high-risk children who experience recent syncope. However, the rate of life-threatening cardiac events in high-risk children who are treated with this mode of medical therapy is still considerable, with an average annual event rate of 2% while on medical therapy. These findings suggest that careful follow-up is warranted in LQTS children because risk factors for life-threatening cardiac events in this population are time dependent and age specific, resulting in a substantial variability in the phenotypic expression of LQTS during long-term follow-up. See p 2184.


*    Long-QT Syndrome After Age 40
 
The congenital long-QT syndrome (LQTS) is associated with increased risk for ventricular tachyarrhythmias . . . [Full Text of this Article]


Related Articles:

Stromal Cell–Derived Factor-1{alpha} Is Cardioprotective After Myocardial Infarction
Ankur Saxena, Jason E. Fish, Michael D. White, Sangho Yu, James W.P. Smyth, Robin M. Shaw, J. Michael DiMaio, and Deepak Srivastava
Circulation 2008 117: 2224-2231. [Abstract] [Full Text]

Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome
Ilan Goldenberg, Arthur J. Moss, Derick R. Peterson, Scott McNitt, Wojciech Zareba, Mark L. Andrews, Jennifer L. Robinson, Emanuela H. Locati, Michael J. Ackerman, Jesaia Benhorin, Elizabeth S. Kaufman, Carlo Napolitano, Silvia G. Priori, Ming Qi, Peter J. Schwartz, Jeffrey A. Towbin, G. Michael Vincent, and Li Zhang
Circulation 2008 117: 2184-2191. [Abstract] [Full Text]

Long-QT Syndrome After Age 40
Ilan Goldenberg, Arthur J. Moss, James Bradley, Slava Polonsky, Derick R. Peterson, Scott McNitt, Wojciech Zareba, Mark L. Andrews, Jennifer L. Robinson, Michael J. Ackerman, Jesaia Benhorin, Elizabeth S. Kaufman, Emanuela H. Locati, Carlo Napolitano, Silvia G. Priori, Ming Qi, Peter J. Schwartz, Jeffrey A. Towbin, G. Michael Vincent, and Li Zhang
Circulation 2008 117: 2192-2201. [Abstract] [Full Text]

Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis
Andreas J. Flammer, Isabella Sudano, Frank Hermann, Steffen Gay, Adrian Forster, Michel Neidhart, Peter Künzler, Frank Enseleit, Daniel Périat, Matthias Hermann, Juerg Nussberger, Thomas F. Luscher, Roberto Corti, Georg Noll, and Frank Ruschitzka
Circulation 2008 117: 2262-2269. [Abstract] [Full Text]

Effects of Off-Pump Versus On-Pump Coronary Artery Bypass Grafting on Early and Late Right Ventricular Function
Tammy J. Pegg, Joseph B. Selvanayagam, Theodoros D. Karamitsos, Ranjit J. Arnold, Jane M. Francis, Stefan Neubauer, and David P. Taggart
Circulation 2008 117: 2202-2210. [Abstract] [Full Text]

Noncanonical Wnt11 Signaling Is Sufficient to Induce Cardiomyogenic Differentiation in Unfractionated Bone Marrow Mononuclear Cells
Michael P. Flaherty, Ahmed Abdel-Latif, Qianhong Li, Greg Hunt, Smita Ranjan, Qinghu Ou, Xian-Liang Tang, Robin K. Johnson, Roberto Bolli, and Buddhadeb Dawn
Circulation 2008 117: 2241-2252. [Abstract] [Full Text]

Inflammation, Oxidative Stress, and Repair Capacity of the Vascular Endothelium in Obstructive Sleep Apnea
Sanja Jelic, Margherita Padeletti, Steven M. Kawut, Christopher Higgins, Stephen M. Canfield, Duygu Onat, Paolo C. Colombo, Robert C. Basner, Phillip Factor, and Thierry H. LeJemtel
Circulation 2008 117: 2270-2278. [Abstract] [Full Text]

Spontaneous Myocardial Infarction in Mice Lacking All Nitric Oxide Synthase Isoforms
Sei Nakata, Masato Tsutsui, Hiroaki Shimokawa, Osamu Suda, Tsuyoshi Morishita, Kiyoko Shibata, Yasuko Yatera, Ken Sabanai, Akihide Tanimoto, Machiko Nagasaki, Hiromi Tasaki, Yasuyuki Sasaguri, Yasuhide Nakashima, Yutaka Otsuji, and Nobuyuki Yanagihara
Circulation 2008 117: 2211-2223. [Abstract] [Full Text]

Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-{gamma}, and Proinflammatory Adipokines
Christine Guo, Vincent Ricchiuti, Bill Q. Lian, Tham M. Yao, Patricia Coutinho, José R. Romero, Jianmin Li, Gordon H. Williams, and Gail K. Adler
Circulation 2008 117: 2253-2261. [Abstract] [Full Text]

Thymosin β4 Is an Essential Paracrine Factor of Embryonic Endothelial Progenitor Cell–Mediated Cardioprotection
Rabea Hinkel, Chiraz El-Aouni, Tonia Olson, Jan Horstkotte, Stefan Mayer, Sebastian Müller;, Michael Willhauck, Christine Spitzweg, Franz-Josef Gildehaus, Wolfgang Münzing, Ewald Hannappel, Ildiko Bock-Marquette, J. Michael DiMaio, Antonis K. Hatzopoulos, Peter Boekstegers, and Christian Kupatt
Circulation 2008 117: 2232-2240. [Abstract] [Full Text]